MBX Biosciences Earnings
NASDAQ: MBXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Thu, Nov 5, 2026
Fiscal period
Sep/2026
EPS estimate
$-0.80
MBX Biosciences earnings summary
MBX Biosciences is scheduled to report Sep/2026 earnings on Nov 5, 2026, with analysts expecting EPS of $-0.80. In its most recent report on Aug 6, 2026 (Q2 2026), MBX posted EPS of $-0.78. Across the last 8 reports, MBX shares moved an average of 10.3% (in either direction) in the first trading session after results, rising 4 times and falling 4 times.
Summary generated from market data by MetaCap's automated system. Methodology
MBX earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 6, 2026 | — | $-0.78 | — | +1.1% |
| May 7, 2026 | — | $-0.50 | — | -20.8% |
| Mar 12, 2026 | — | $-0.46 | — | +2.4% |
| Nov 6, 2025 | — | $-0.63 | — | -3.1% |
| Aug 7, 2025 | — | $-0.58 | — | +21.0% |
| May 12, 2025 | — | $-0.71 | — | +8.9% |
| Mar 17, 2025 | — | $19.84 | — | -1.6% |
| Nov 7, 2024 | — | $-2.78 | — | -23.1% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.